{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:08:11Z","timestamp":1789470491321,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","award":["5U01FD005946-05"],"award-info":[{"award-number":["5U01FD005946-05"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.josat.2025.209858","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T23:09:42Z","timestamp":1765148982000},"page":"209858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Real-world longitudinal treatment trajectories following opioid use disorder diagnosis among commercially insured beneficiaries in the United States"],"prefix":"10.1016","volume":"182","author":[{"given":"John G.","family":"Rizk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danya M.","family":"Qato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannat","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"DiPaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abree","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7\u20138","key":"10.1016\/j.josat.2025.209858_bb0005","first-page":"8","article-title":"Methadone treatment of opiate addiction: A systematic review of comparative studies","volume":"14","author":"Ali","year":"2017","journal-title":"Innovations in Clinical Neuroscience"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/MLR.0000000000001838","article-title":"Measurement approaches to estimating methadone continuity in opioid use disorder care","volume":"61","author":"Busch","year":"2023","journal-title":"Medical Care"},{"key":"10.1016\/j.josat.2025.209858_bb0015","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs (report no. SMA 12-4214)","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.josat.2025.209858_bb0020","series-title":"U.S. overdose deaths decrease almost 27% in 2024","author":"Centers for Disease Control and Prevention","year":"2025"},{"issue":"7","key":"10.1016\/j.josat.2025.209858_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.2014","article-title":"Insurance instability for patients with opioid use disorder in the year after diagnosis","volume":"5","author":"Christine","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"1","key":"10.1016\/j.josat.2025.209858_bb0030","doi-asserted-by":"crossref","DOI":"10.52965\/001c.27241","article-title":"Buprenorphine for chronic pain: A safer alternative to traditional opioids","volume":"9","author":"Dalal","year":"2021","journal-title":"Health Psychology Research"},{"key":"10.1016\/j.josat.2025.209858_bb0035","series-title":"Expanding access to addiction treatment","author":"Gastala","year":"2024"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0040","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: A chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209858_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"2S Suppl 1","key":"10.1016\/j.josat.2025.209858_bb0050","article-title":"The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0055","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2025.209858_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society of Addiction Medicine consensus panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209858_bb0065","article-title":"Opioid use disorder: Current trends and potential treatments","volume":"11","author":"Lee","year":"2023","journal-title":"Frontiers in Public Health"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/add.13270","article-title":"Association between trajectories of buprenorphine treatment and emergency department and inpatient utilization","volume":"111","author":"Lo-Ciganic","year":"2016","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2025.209858_bb0075","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2025.209858_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to medication for opioid use disorder across U.S. census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2025.209858_bb0085","author":"National Institute on Drug Abuse"},{"key":"10.1016\/j.josat.2025.209858_bb0090","author":"NetworkD3"},{"issue":"12","key":"10.1016\/j.josat.2025.209858_bb0095","article-title":"Buprenorphine\/naloxone vs methadone for the treatment of opioid use disorder","volume":"332","author":"Nosyk","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2025.209858_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100130","article-title":"Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States","volume":"6","author":"Pollack","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"4","key":"10.1016\/j.josat.2025.209858_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301863","article-title":"County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities","volume":"19","author":"Rizk","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.josat.2025.209858_bb0110","series-title":"AcademyHealth annual research meeting, Baltimore, MD, United States","article-title":"Early opioid use disorder treatment pathways and determinants among the commercially insured, 2010\u20132019 [poster presentation]","author":"Saini","year":"2024"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0115","doi-asserted-by":"crossref","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid","volume":"39","author":"Samples","year":"2020","journal-title":"Health Affairs"},{"issue":"2","key":"10.1016\/j.josat.2025.209858_bb0120","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000128","article-title":"Treatment pathways leading to biologic therapies for ulcerative colitis and Crohn\u2019s disease in the United States","volume":"11","author":"Siegel","year":"2020","journal-title":"Clinical and Translational Gastroenterology"},{"key":"10.1016\/j.josat.2025.209858_bb0125","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.josat.2025.209858_bb0130","doi-asserted-by":"crossref","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care","volume":"20","author":"Stein","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2025.209858_bb0135","series-title":"Methadone take-home flexibilities extension guidance","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"key":"10.1016\/j.josat.2025.209858_bb0140","series-title":"Naltrexone","author":"Substance Abuse and Mental Health Services Administration","year":"2024"},{"issue":"5","key":"10.1016\/j.josat.2025.209858_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14328","article-title":"Trends in methadone dispensing for opioid use disorder after Medicare payment policy changes","volume":"6","author":"Taylor","year":"2023","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.josat.2025.209858_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.2052","article-title":"Quality of opioid use disorder treatment for persons with and without disabling conditions","volume":"6","author":"Thomas","year":"2023","journal-title":"JAMA Network Open"},{"issue":"1","key":"10.1016\/j.josat.2025.209858_bb0155","doi-asserted-by":"crossref","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.josat.2025.209858_bb0160","author":"U.S. Food and Drug Administration"},{"issue":"2","key":"10.1016\/j.josat.2025.209858_bb0165","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder","volume":"177","author":"Williams","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.josat.2025.209858_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002963","article-title":"Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment","volume":"16","author":"Yedinak","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.josat.2025.209858_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108686","article-title":"Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data","volume":"136","author":"Zhang","year":"2022","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925002371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925002371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:23:21Z","timestamp":1770740601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925002371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"alternative-id":["S2949875925002371"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209858","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world longitudinal treatment trajectories following opioid use disorder diagnosis among commercially insured beneficiaries in the United States","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209858"}}